OptraScan provies automated scanning and high resolution imaging to convert glass slides into mages.
OptraScan has raised $30.0M in total funding. The most recent round was Series B. The last funding was announced in November 2024.
OptraScan's investors include Molbio Diagnostics.
OptraScan is headquartered in San Jose, United States.
OptraScan provies automated scanning and high resolution imaging to convert glass slides into mages.
OptraScan is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OptraScan — Funding & Investors." VCBacked, November 6, 2024, https://www.vcbacked.co/company/optrascan. Accessed October 29, 2026.
VCBacked. (2024). OptraScan — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/optrascan
{{cite web |title=OptraScan — Funding & Investors |url=https://www.vcbacked.co/company/optrascan |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated